The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
BCG Tuberculosis (TB) Vaccine-Global Market Insights and Sales Trends 2024
Synopsis
BCG Tuberculosis (TB) Vaccine is a vaccine primarily used against tuberculosis.
The global BCG Tuberculosis (TB) Vaccine market size is expected to reach US$ 36 million by 2029, growing at a CAGR of 2.9% from 2023 to 2029. The market is mainly driven by the significant applications of BCG Tuberculosis (TB) Vaccine in various end use industries. The expanding demands from the Hospital and Clinic, are propelling BCG Tuberculosis (TB) Vaccine market. Immune BCG, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Therapy BCG segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for BCG Tuberculosis (TB) Vaccine, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global BCG Tuberculosis (TB) Vaccine market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global BCG Tuberculosis (TB) Vaccine market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, BCG Tuberculosis (TB) Vaccine sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of BCG Tuberculosis (TB) Vaccine covered in this report include Merck, Sanofi Pasteur, Japan BCG Lab, China National Biotec, Serum Institute of India, Intervax and GSBPL, etc.
The global BCG Tuberculosis (TB) Vaccine market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Merck
Sanofi Pasteur
Japan BCG Lab
China National Biotec
Serum Institute of India
Intervax
GSBPL
Global BCG Tuberculosis (TB) Vaccine market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global BCG Tuberculosis (TB) Vaccine market, Segment by Type:
Immune BCG
Therapy BCG
Global BCG Tuberculosis (TB) Vaccine market, by Application
Hospital
Clinic
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of BCG Tuberculosis (TB) Vaccine manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of BCG Tuberculosis (TB) Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
BCG Tuberculosis (TB) Vaccine is a vaccine primarily used against tuberculosis.
The global BCG Tuberculosis (TB) Vaccine market size is expected to reach US$ 36 million by 2029, growing at a CAGR of 2.9% from 2023 to 2029. The market is mainly driven by the significant applications of BCG Tuberculosis (TB) Vaccine in various end use industries. The expanding demands from the Hospital and Clinic, are propelling BCG Tuberculosis (TB) Vaccine market. Immune BCG, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Therapy BCG segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for BCG Tuberculosis (TB) Vaccine, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global BCG Tuberculosis (TB) Vaccine market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global BCG Tuberculosis (TB) Vaccine market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, BCG Tuberculosis (TB) Vaccine sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of BCG Tuberculosis (TB) Vaccine covered in this report include Merck, Sanofi Pasteur, Japan BCG Lab, China National Biotec, Serum Institute of India, Intervax and GSBPL, etc.
The global BCG Tuberculosis (TB) Vaccine market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Merck
Sanofi Pasteur
Japan BCG Lab
China National Biotec
Serum Institute of India
Intervax
GSBPL
Global BCG Tuberculosis (TB) Vaccine market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global BCG Tuberculosis (TB) Vaccine market, Segment by Type:
Immune BCG
Therapy BCG
Global BCG Tuberculosis (TB) Vaccine market, by Application
Hospital
Clinic
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of BCG Tuberculosis (TB) Vaccine manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of BCG Tuberculosis (TB) Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index1 BCG Tuberculosis (TB) Vaccine Market Overview
1.1 BCG Tuberculosis (TB) Vaccine Product Overview
1.2 BCG Tuberculosis (TB) Vaccine Market Segment by Type
1.2.1 Immune BCG
1.2.2 Therapy BCG
1.3 Global BCG Tuberculosis (TB) Vaccine Market Size by Type
1.3.1 Global BCG Tuberculosis (TB) Vaccine Market Size Overview by Type (2018-2029)
1.3.2 Global BCG Tuberculosis (TB) Vaccine Historic Market Size Review by Type (2018-2023)
1.3.3 Global BCG Tuberculosis (TB) Vaccine Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America BCG Tuberculosis (TB) Vaccine Sales Breakdown by Type (2018-2023)
1.4.2 Europe BCG Tuberculosis (TB) Vaccine Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific BCG Tuberculosis (TB) Vaccine Sales Breakdown by Type (2018-2023)
1.4.4 Latin America BCG Tuberculosis (TB) Vaccine Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa BCG Tuberculosis (TB) Vaccine Sales Breakdown by Type (2018-2023)
2 Global BCG Tuberculosis (TB) Vaccine Market Competition by Company
2.1 Global Top Players by BCG Tuberculosis (TB) Vaccine Sales (2018-2023)
2.2 Global Top Players by BCG Tuberculosis (TB) Vaccine Revenue (2018-2023)
2.3 Global Top Players by BCG Tuberculosis (TB) Vaccine Price (2018-2023)
2.4 Global Top Manufacturers BCG Tuberculosis (TB) Vaccine Manufacturing Base Distribution, Sales Area, Product Type
2.5 BCG Tuberculosis (TB) Vaccine Market Competitive Situation and Trends
2.5.1 BCG Tuberculosis (TB) Vaccine Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by BCG Tuberculosis (TB) Vaccine Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in BCG Tuberculosis (TB) Vaccine as of 2022)
2.7 Date of Key Manufacturers Enter into BCG Tuberculosis (TB) Vaccine Market
2.8 Key Manufacturers BCG Tuberculosis (TB) Vaccine Product Offered
2.9 Mergers & Acquisitions, Expansion
3 BCG Tuberculosis (TB) Vaccine Status and Outlook by Region
3.1 Global BCG Tuberculosis (TB) Vaccine Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global BCG Tuberculosis (TB) Vaccine Historic Market Size by Region
3.2.1 Global BCG Tuberculosis (TB) Vaccine Sales in Volume by Region (2018-2023)
3.2.2 Global BCG Tuberculosis (TB) Vaccine Sales in Value by Region (2018-2023)
3.2.3 Global BCG Tuberculosis (TB) Vaccine Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global BCG Tuberculosis (TB) Vaccine Forecasted Market Size by Region
3.3.1 Global BCG Tuberculosis (TB) Vaccine Sales in Volume by Region (2024-2029)
3.3.2 Global BCG Tuberculosis (TB) Vaccine Sales in Value by Region (2024-2029)
3.3.3 Global BCG Tuberculosis (TB) Vaccine Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global BCG Tuberculosis (TB) Vaccine by Application
4.1 BCG Tuberculosis (TB) Vaccine Market Segment by Application
4.1.1 Hospital
4.1.2 Clinic
4.2 Global BCG Tuberculosis (TB) Vaccine Market Size by Application
4.2.1 Global BCG Tuberculosis (TB) Vaccine Market Size Overview by Application (2018-2029)
4.2.2 Global BCG Tuberculosis (TB) Vaccine Historic Market Size Review by Application (2018-2023)
4.2.3 Global BCG Tuberculosis (TB) Vaccine Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America BCG Tuberculosis (TB) Vaccine Sales Breakdown by Application (2018-2023)
4.3.2 Europe BCG Tuberculosis (TB) Vaccine Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific BCG Tuberculosis (TB) Vaccine Sales Breakdown by Application (2018-2023)
4.3.4 Latin America BCG Tuberculosis (TB) Vaccine Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa BCG Tuberculosis (TB) Vaccine Sales Breakdown by Application (2018-2023)
5 North America BCG Tuberculosis (TB) Vaccine by Country
5.1 North America BCG Tuberculosis (TB) Vaccine Historic Market Size by Country
5.1.1 North America BCG Tuberculosis (TB) Vaccine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America BCG Tuberculosis (TB) Vaccine Sales in Volume by Country (2018-2023)
5.1.3 North America BCG Tuberculosis (TB) Vaccine Sales in Value by Country (2018-2023)
5.2 North America BCG Tuberculosis (TB) Vaccine Forecasted Market Size by Country
5.2.1 North America BCG Tuberculosis (TB) Vaccine Sales in Volume by Country (2024-2029)
5.2.2 North America BCG Tuberculosis (TB) Vaccine Sales in Value by Country (2024-2029)
6 Europe BCG Tuberculosis (TB) Vaccine by Country
6.1 Europe BCG Tuberculosis (TB) Vaccine Historic Market Size by Country
6.1.1 Europe BCG Tuberculosis (TB) Vaccine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe BCG Tuberculosis (TB) Vaccine Sales in Volume by Country (2018-2023)
6.1.3 Europe BCG Tuberculosis (TB) Vaccine Sales in Value by Country (2018-2023)
6.2 Europe BCG Tuberculosis (TB) Vaccine Forecasted Market Size by Country
6.2.1 Europe BCG Tuberculosis (TB) Vaccine Sales in Volume by Country (2024-2029)
6.2.2 Europe BCG Tuberculosis (TB) Vaccine Sales in Value by Country (2024-2029)
7 Asia-Pacific BCG Tuberculosis (TB) Vaccine by Region
7.1 Asia-Pacific BCG Tuberculosis (TB) Vaccine Historic Market Size by Region
7.1.1 Asia-Pacific BCG Tuberculosis (TB) Vaccine Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific BCG Tuberculosis (TB) Vaccine Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific BCG Tuberculosis (TB) Vaccine Sales in Value by Region (2018-2023)
7.2 Asia-Pacific BCG Tuberculosis (TB) Vaccine Forecasted Market Size by Region
7.2.1 Asia-Pacific BCG Tuberculosis (TB) Vaccine Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific BCG Tuberculosis (TB) Vaccine Sales in Value by Region (2024-2029)
8 Latin America BCG Tuberculosis (TB) Vaccine by Country
8.1 Latin America BCG Tuberculosis (TB) Vaccine Historic Market Size by Country
8.1.1 Latin America BCG Tuberculosis (TB) Vaccine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America BCG Tuberculosis (TB) Vaccine Sales in Volume by Country (2018-2023)
8.1.3 Latin America BCG Tuberculosis (TB) Vaccine Sales in Value by Country (2018-2023)
8.2 Latin America BCG Tuberculosis (TB) Vaccine Forecasted Market Size by Country
8.2.1 Latin America BCG Tuberculosis (TB) Vaccine Sales in Volume by Country (2024-2029)
8.2.2 Latin America BCG Tuberculosis (TB) Vaccine Sales in Value by Country (2024-2029)
9 Middle East and Africa BCG Tuberculosis (TB) Vaccine by Country
9.1 Middle East and Africa BCG Tuberculosis (TB) Vaccine Historic Market Size by Country
9.1.1 Middle East and Africa BCG Tuberculosis (TB) Vaccine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa BCG Tuberculosis (TB) Vaccine Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa BCG Tuberculosis (TB) Vaccine Sales in Value by Country (2018-2023)
9.2 Middle East and Africa BCG Tuberculosis (TB) Vaccine Forecasted Market Size by Country
9.2.1 Middle East and Africa BCG Tuberculosis (TB) Vaccine Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa BCG Tuberculosis (TB) Vaccine Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Merck
10.1.1 Merck Company Information
10.1.2 Merck Introduction and Business Overview
10.1.3 Merck BCG Tuberculosis (TB) Vaccine Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Merck BCG Tuberculosis (TB) Vaccine Products Offered
10.1.5 Merck Recent Development
10.2 Sanofi Pasteur
10.2.1 Sanofi Pasteur Company Information
10.2.2 Sanofi Pasteur Introduction and Business Overview
10.2.3 Sanofi Pasteur BCG Tuberculosis (TB) Vaccine Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Sanofi Pasteur BCG Tuberculosis (TB) Vaccine Products Offered
10.2.5 Sanofi Pasteur Recent Development
10.3 Japan BCG Lab
10.3.1 Japan BCG Lab Company Information
10.3.2 Japan BCG Lab Introduction and Business Overview
10.3.3 Japan BCG Lab BCG Tuberculosis (TB) Vaccine Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Japan BCG Lab BCG Tuberculosis (TB) Vaccine Products Offered
10.3.5 Japan BCG Lab Recent Development
10.4 China National Biotec
10.4.1 China National Biotec Company Information
10.4.2 China National Biotec Introduction and Business Overview
10.4.3 China National Biotec BCG Tuberculosis (TB) Vaccine Sales, Revenue and Gross Margin (2018-2023)
10.4.4 China National Biotec BCG Tuberculosis (TB) Vaccine Products Offered
10.4.5 China National Biotec Recent Development
10.5 Serum Institute of India
10.5.1 Serum Institute of India Company Information
10.5.2 Serum Institute of India Introduction and Business Overview
10.5.3 Serum Institute of India BCG Tuberculosis (TB) Vaccine Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Serum Institute of India BCG Tuberculosis (TB) Vaccine Products Offered
10.5.5 Serum Institute of India Recent Development
10.6 Intervax
10.6.1 Intervax Company Information
10.6.2 Intervax Introduction and Business Overview
10.6.3 Intervax BCG Tuberculosis (TB) Vaccine Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Intervax BCG Tuberculosis (TB) Vaccine Products Offered
10.6.5 Intervax Recent Development
10.7 GSBPL
10.7.1 GSBPL Company Information
10.7.2 GSBPL Introduction and Business Overview
10.7.3 GSBPL BCG Tuberculosis (TB) Vaccine Sales, Revenue and Gross Margin (2018-2023)
10.7.4 GSBPL BCG Tuberculosis (TB) Vaccine Products Offered
10.7.5 GSBPL Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 BCG Tuberculosis (TB) Vaccine Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 BCG Tuberculosis (TB) Vaccine Industrial Chain Analysis
11.4 BCG Tuberculosis (TB) Vaccine Market Dynamics
11.4.1 BCG Tuberculosis (TB) Vaccine Industry Trends
11.4.2 BCG Tuberculosis (TB) Vaccine Market Drivers
11.4.3 BCG Tuberculosis (TB) Vaccine Market Challenges
11.4.4 BCG Tuberculosis (TB) Vaccine Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 BCG Tuberculosis (TB) Vaccine Distributors
12.3 BCG Tuberculosis (TB) Vaccine Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
